Metropolis Healthcare Limited (BOM:542650)
India
· Delayed Price · Currency is INR 1,667.15
+6.55 (0.39%)
At close: May 9, 2025
Metropolis Healthcare Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
| Net Income | 1,278 | 1,429 | 2,142 | 1,831 | 1,273 | Upgrade
|
| Depreciation & Amortization | 846.45 | 806.27 | 562.1 | 410.4 | 370.12 | Upgrade
|
| Other Amortization | 98.23 | 85.89 | 70.13 | 49.05 | 22.55 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -0.08 | 0.16 | 0.11 | 6 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 1.35 | 2.22 | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -11.56 | -6.78 | -4.26 | -4.91 | 24.64 | Upgrade
|
| Loss (Gain) on Equity Investments | - | - | - | - | 5.2 | Upgrade
|
| Stock-Based Compensation | 14.16 | 2.85 | 68.57 | 77.88 | 7.24 | Upgrade
|
| Provision & Write-off of Bad Debts | 113.52 | -21.72 | -28.48 | 217.35 | 350 | Upgrade
|
| Other Operating Activities | 247.21 | 103.19 | -115.54 | 62.53 | -188.73 | Upgrade
|
| Change in Accounts Receivable | -123.7 | 157.72 | 115.87 | -164.64 | -265.84 | Upgrade
|
| Change in Inventory | 58.98 | 65.15 | -79.37 | -161.48 | 17.02 | Upgrade
|
| Change in Accounts Payable | 57 | -53.12 | -165.07 | 234.42 | 316.33 | Upgrade
|
| Change in Other Net Operating Assets | 62.24 | -98.64 | -35.41 | -61.36 | 212.23 | Upgrade
|
| Operating Cash Flow | 2,641 | 2,471 | 2,533 | 2,490 | 2,150 | Upgrade
|
| Operating Cash Flow Growth | 6.87% | -2.44% | 1.70% | 15.83% | 138.49% | Upgrade
|
| Capital Expenditures | -637.61 | -526.34 | -306.63 | -282.73 | -362.07 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 1.49 | - | 0.86 | 2.63 | Upgrade
|
| Cash Acquisitions | -6.5 | -4.51 | -6,379 | -53.95 | -123.79 | Upgrade
|
| Investment in Securities | -271.66 | 932.29 | -800.44 | 848.52 | -606.37 | Upgrade
|
| Other Investing Activities | 21.65 | 65.01 | 110.62 | 104.3 | 41.29 | Upgrade
|
| Investing Cash Flow | -894.12 | 467.94 | -7,376 | 617.01 | -1,048 | Upgrade
|
| Long-Term Debt Issued | - | - | 6,000 | - | - | Upgrade
|
| Total Debt Issued | - | - | 6,000 | - | - | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | -175.79 | Upgrade
|
| Long-Term Debt Repaid | -1,382 | -2,242 | -3,791 | -179.83 | -134.92 | Upgrade
|
| Total Debt Repaid | -1,382 | -2,242 | -3,791 | -179.83 | -310.71 | Upgrade
|
| Net Debt Issued (Repaid) | -1,382 | -2,242 | 2,209 | -179.83 | -310.71 | Upgrade
|
| Issuance of Common Stock | 0.03 | 1.84 | 19.75 | 343.18 | 318.93 | Upgrade
|
| Common Dividends Paid | -204.96 | -409.69 | -409.38 | -408.93 | -401.43 | Upgrade
|
| Other Financing Activities | -224.8 | -273.24 | -194.48 | -81.32 | -160.02 | Upgrade
|
| Financing Cash Flow | -1,812 | -2,923 | 1,625 | -326.9 | -553.23 | Upgrade
|
| Foreign Exchange Rate Adjustments | 3.25 | 12.97 | -13.64 | 13.8 | 9.57 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | 25.29 | - | - | Upgrade
|
| Net Cash Flow | -62.15 | 28.53 | -3,206 | 2,794 | 558.03 | Upgrade
|
| Free Cash Flow | 2,003 | 1,945 | 2,226 | 2,208 | 1,788 | Upgrade
|
| Free Cash Flow Growth | 3.01% | -12.65% | 0.84% | 23.47% | 153.28% | Upgrade
|
| Free Cash Flow Margin | 16.59% | 16.94% | 18.12% | 22.12% | 20.88% | Upgrade
|
| Free Cash Flow Per Share | 38.98 | 37.85 | 43.30 | 43.15 | 35.45 | Upgrade
|
| Cash Interest Paid | 224.8 | 273.24 | 183.84 | 73.08 | 77.51 | Upgrade
|
| Cash Income Tax Paid | 373.84 | 515.8 | 825.12 | 568.32 | 726.8 | Upgrade
|
| Levered Free Cash Flow | 1,757 | 1,280 | 1,723 | 1,971 | 1,812 | Upgrade
|
| Unlevered Free Cash Flow | 1,898 | 1,448 | 1,846 | 2,020 | 1,864 | Upgrade
|
| Change in Net Working Capital | -357.51 | 194.32 | 308.19 | -250.79 | -612.59 | Upgrade
|
Updated Feb 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.